Targeted radiation for people with many solid tumor metastases
Part of Cancer clinical trials.
This trial tests a precise type of radiation that targets multiple tumor spots in a carefully planned way. It may help people with many metastatic (spread) solid tumors when standard treatments aren’t working or can’t be used.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give informed consent (or your legal representative can)
- You must be an adult (18 or older) and able to do daily activities (Karnofsky score above 60)
- You have widespread (polymetastatic) solid tumors: more than 5 spots, with at least one larger than 2 cm
- Your doctors must think standard treatment isn’t working or you can’t get it, and you must have limited treatment options
- You must be able to get a CT scan for treatment planning
- You must be off systemic cancer therapy for at least 1 month before and 1 month after the treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests powerful, precisely aimed radiation (MR-guided stereotactic body radiation therapy) in a single session to treat 1 to 3 small metastatic tumors outside the brain and spine. It aims to control cancer growth with fewer visits and less impact on healthy tissue.
This trial uses a special PET scan to guide radiation therapy for painful spots where cancer has spread to the bone. The goal is to treat the pain more precisely and see if this image-guided approach works well.
This trial compares two stereotactic radiation strategies for patients who have intact (not previously radiated) brain metastases that are limited in size. It aims to see which approach works best in controlling the cancer while reducing side effects.
This trial tests whether adding focused, high-dose radiation (SABR) to standard drug therapy can better control cancer that has spread to a few spots in the body. It is for people starting or resuming cancer medicines for newly found or growing metastases.
This study tests whether a focused, high-precision type of radiation can control many cancer spread-out spots (“metastases”) at the same time, while keeping side effects acceptable. It may help people with many metastases live longer or have better disease control by aiming treatment at every treatable spot.
This trial studies whether stereotactic (high-precision) radiation given in a few sessions can control rare cancers that have spread to a small number of sites. It aims to help by treating all known spots while keeping side effects manageable.
Hear when a new Metastatic Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.